Interleukin-6 blocker for successful outcome of late-onset rheumatoid oligoarthritis

Journal Title: IP International Journal of Orthopaedic Rheumatology - Year 2017, Vol 3, Issue 1

Abstract

Newer cytokine therapies have revolutionised the management of Rheumatoid arthritis. Atypical oligoarthritis can also be a manifestation of RA and CCP antibodies have been proven to be most specific for Rheumatoid. Our patient had 2 years of painful ankle bilaterally and suggested for joint replacement due to osteoarthritis changes. After the diagnosis of RA using Anti-CCP antibodies, we elected to give Tocilizumab(IL 6 Blocker) which had made the patient to walk without wheelchair after 2 years. This suggests early appropriate diagnosis is the key and Biologics- the new Kid in the market- has proven to be effective in early Rheumatoid arthritis.

Authors and Affiliations

Yuva Vishalini Ravindran, Subramanian Nallasivan

Keywords

Related Articles

Ultrasound-guided steroid injection: A scintillating dimension in managing de Quervain's tenosynovitis

Introduction de Quervain39s tenosynovitis is a stenosing tenosynovitis of the first extensor compartment of the wrist and leads to wrist pain along with impaired function of the wrist and hand Local steroid injection and...

Hirayama Disease: A rare case report with involvement of cervical spine

Introduction: Hirayama disease is a type of cervical myelopathy, also termed non progressive juvenile spinal muscular atrophy mainly involves forearm and hand means distal part of upper extremities. It’s mainly affects t...

Knowledge, attitude and perception of gingival pigmentation among students aged 18-23 Years in UP, India

Background: The clinical appearance of sound gingiva differs from individual to individual and even at different sites in the oral cavity. Some characteristics are genetically influenced; others appear to be determined b...

USOFRA study using QUS Ultrasound of the heel bone to detect osteoporosis demonstrating height loss as a vital risk factor in women

Background: Osteoporosis, is a silent progressive disease associated with low bone density and resultant deterioration of bone micro architecture and fragility fractures. Unfortunately, the Dexa-Scan is not widely availa...

Download PDF file
  • EP ID EP298455
  • DOI 10.18231/2455-6777 .2017.0007
  • Views 78
  • Downloads 0

How To Cite

Yuva Vishalini Ravindran, Subramanian Nallasivan (2017). Interleukin-6 blocker for successful outcome of late-onset rheumatoid oligoarthritis. IP International Journal of Orthopaedic Rheumatology, 3(1), 35-36. https://europub.co.uk/articles/-A-298455